1. Altamura, S., Tomei, L., Koch, U., Neuner, P.J.S., Summa, V., 2000. Diketoacid-derivatives as inhibitors of polymerases. International Patent WO 0006529, IRBM.
2. Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P′2 moiety with improved potency;Arasappan;Bioorg. Med. Chem. Let.,2005
3. Babine, R.E., Chen, S.H., Lamar, J.E., Snyder, N.J., Sun, X.D., Tebbe, M.J., Victor, F., Wang, Q.M., Yip, Y.Y.M., Collado, I., Garcia-Paredes, C., Parker, R.S., Jing, L., Guo, D., Glass, J.I., 2002. Peptidomimetic protease inhibitors. International Patent WO 02018369, Eli Lilly and Co.
4. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type protease required for cleavage at the NS3/4 and NS4/5 junctions;Bartenschlager;J. Virol.,1993
5. The safety and efficacy of viramidine® plus pegylated interferon alfa-2b versus ribavirin plus pegylated interferon alfa-2b in therapy-naïve patients infected with hcv: phase 3 results;Benhamou,2006